RECEPTOR AI

Updated 40 days ago
Private Limited Company
  • Active - 14158915 (CH)
  • Age: 1 year
  • ID: 52796426/1
Ground floor-20, United Kingdom, 20-22 Wenlock Road, London N1 7GU
CLICK HERE TO SEE DETAILS OF COMPANY CHANGES
• 72110 - Research and experimental development on biotechnology
• 72190 - Other research and experimental development on natural sciences and engineering
• 74909 - Other professional, scientific and technical activities n.e.c.
RECEPTOR.AI provides an end-to-end small molecule drug discovery platform for precision and personalised medicine to achieve ultimate selectivity between highly similar off-target proteins... RECEPTOR.AI's mission is to create superior drugs, which are safe, efficient and successful in clinical trials by developing a next generation drug discovery platform based on the synergy of AI, computational chemistry and biology... We aim to improve access to AI drug discovery via our AI platform which is integrated with wet labs to make the drug discovery process more efficient.
Also known as: receptor, Receptor.ai Inc., RECEPTOR.AI LTD
Registration numbers: 14158915 (CH)
Primary location: London United Kingdom
  • 0
  • 0
Interest Score
2
HIT Score
0.83
CEO
Dr. Alan Nafiev
CTO
Dr. Sergii Starosyla
Founder
Dr. Alan Nafiev, Dr. Sergii Starosyla

UK Company Data

Company number
14158915		 Account category
TOTAL EXEMPTION FULL		 Account ref. day
30		 Account ref. month
6
Accounts next due date
2025-03-31		 Accounts last made up date
2023-06-30		 Returns next due date
2023-07-06		 Returns last made up date
N/A
Num. mort. charges
0		 Num. mort. outstanding
0		 Num. mort. part. satisfied
0		 Num. mort. satisfied
0
Num. gen. partners
0		 Num. lim. partners
0
Domain
receptor.ai
Actual
www.receptor.ai
IP
34.249.200.254, 52.17.119.105, 63.35.51.142
Status
OK
Category
Company
0 comments Add a comment